Communiqués Fluicell AB

Actions

Marché Fermé - Nasdaq Stockholm 18:00:00 30/09/2026			Varia. 5j.	Varia. 1 janv.
29,30 ^SEK	-2,66%		-3,30%	+193,00%

15/09	Fluicell : règlement d'une créance client de 6 millions de couronnes	FW
28/08	Fluicell AB (publ) publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

02/09/25	Fluicell : and Ambusol enter into exclusive global license and development agreement regarding technology for cancer treatment	PU
22/08/25	Fluicell : receives funding from Breakthrough T1D for collaboration with leading medical university to develop tissue-based type 1 diabetes therapeutics	PU
29/09/21	BioStock: Fluicell partners with big pharma for 3-D bioprinting project	AQ
01/07/21	BioStock: 2021 represents beginning of new era for Fluicell	AQ
18/05/21	BioStock: Fluicell dives into regenerative medicine field	AQ
15/04/21	BioStock: The sales team - a key part of Fluicell's growth	AQ
18/03/21	BioStock: Fluicell launches Biozone 6	AQ
26/01/21	BioStock: 2020 - a year of growth and expansion for Fluicell	AQ
21/12/20	BioStock: Fluicell harnessing microfluidics to spearhead the Biomedical field	AQ
11/11/20	BioStock: Fluicell makes its mark in neuroscience field	AQ
29/10/20	BioStock: Fluicell secures SEK 4 million in directed share issue	AQ
02/09/20	BioStock: Fluicell answers call for new experimental models	AQ
10/06/20	BioStock: Fluicell's CRO services diversify revenue opportunities	AQ
18/05/20	BioStock: Q1 report signals expansion period for Fluicell	AQ
30/04/20	BioStock: Fluicell - pioneers in single-cell technology	AQ
20/03/20	BioStock: Fluicell at the forefront of 3D bioprinting	AQ